ABMD Abiomed Loading...

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
17:59
Aug 26
FirstSquawk Newswire (@FirstSquawk)
FDA issues early alert on Abiomed heart pump controller purge cassette issue with 37 serious.
FDA issues early alert on Abiomed heart pump controller purge cassette issue with 37 serious injuries and 3 deaths reported as of August 17.
ABMD
08:30
Apr 14 ◎
Tim Schmid Executive Vice President, Worldwide Chairman, MedTech, John… JNJ Q1 FY26 call
Abiomed (now JNJ-owned) is experiencing robust growth driven by Impella adoption and positive clinical data, reinforcing JNJ's cardiovascular momentum.
ABMD
HIGH

About ABMD Analyst Coverage

Buzzberg tracks ABMD (Abiomed) across 2 sources. 0 bullish vs 0 bearish calls from 2 analysts. Sentiment: evenly split. 2 total trade ideas tracked. Latest voices: FirstSquawk, Tim Schmid.